...
首页> 外文期刊>Cancer immunology, immunotherapy : >Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients
【24h】

Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients

机译:来自乳腺癌患者T型调节细胞VEGFA表达的转录调控

获取原文
获取原文并翻译 | 示例
           

摘要

The initiation of new blood vessel formation (neo-angiogenesis) is one of the primary requirements for the establishment of tumor. As the tumor grows beyond a certain size, a hypoxic-condition arises in the inner core of tumor, triggering the release of chemokines, which attract T-regulatory (Treg) cells in the tumor-site. The presence of FOXP3, a lineage-specific transcription factor, expressing Treg cells in various types of tumor implements immunosuppressive and tumor-promoting strategies. One such strategy is the invitation of endothelial cells for neo-vascularization in the tumor site. Here we report that as the disease progresses, Treg cells from breast cancer patients are capable of secreting high-amount of VEGFA. The VEGFA promoter lacks Treg-specific transcription factor FOXP3 binding site. FOXP3 in association with locus-specific transcription factor STAT3 binds to VEGFA promoter to induce its transcription in Treg cells obtained from breast cancer patients. Treg cell-secreted VEGFA induces neo-angiogenesis from endothelial cells under in-vitro conditions. Targeting Tregs in mice with breast tumor reduces tumor growth as well as the level of neo-angiogenesis in the tumor tissue.
机译:启动新血管形成(新血管生成)是建立肿瘤的主要条件之一。当肿瘤生长超过一定大小时,肿瘤内部核心出现缺氧状态,触发趋化因子的释放,从而吸引肿瘤部位的T调节(Treg)细胞。FOXP3是一种谱系特异性转录因子,在各种类型的肿瘤中表达Treg细胞,实施免疫抑制和肿瘤促进策略。其中一种策略是邀请内皮细胞在肿瘤部位新生血管。我们在此报告,随着疾病的进展,乳腺癌患者的Treg细胞能够分泌大量VEGFA。VEGFA启动子缺乏Treg特异性转录因子FOXP3结合位点。FOXP3与位点特异性转录因子STAT3结合VEGFA启动子,在乳腺癌患者的Treg细胞中诱导其转录。在体外条件下,由Treg细胞分泌的VEGFA诱导内皮细胞新生血管生成。在患有乳腺肿瘤的小鼠中靶向Tregs可降低肿瘤生长以及肿瘤组织中新血管生成的水平。

著录项

  • 来源
    《Cancer immunology, immunotherapy :》 |2021年第7期|共15页
  • 作者单位

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

    Bose Inst Div Mol Med P-1-12 Calcutta Improvement Trust Scheme 7 M Kolkata 700054 India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Endothelial cell; FOXP3; Treg cells; STAT3; VEGFA; Neo-angiogenesis;

    机译:内皮细胞;Foxp3;Treg细胞;Stat3;VEGFA;新血管生成;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号